# Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male

> **NCT01404598** · PHASE1 · COMPLETED · sponsor: **NicOx** · enrollment: 24 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** naproxcinod 750 bid
- **DRUG:** naproxcinod 3000 mg od
- **DRUG:** naproxen 500 mg bid

## Key facts

- **NCT ID:** NCT01404598
- **Lead sponsor:** NicOx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404598, "Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01404598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*